Actively Recruiting
Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention)
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-11-04
140
Participants Needed
5
Research Sites
102 weeks
Total Duration
On this page
Sponsors
A
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead Sponsor
D
Dutch Cancer Society
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this randomized controlled trial (RCT) is to evaluate the effectiveness of the MiLES intervention targeted at employers, on successful return to work (RTW) of employees with cancer, compared to care as usual (CAU). Secundary objectives are: * To evaluate the cost-effectiveness and return-on-investment of the MiLES intervention on successful RTW and quality of life, compared to CAU. * To evaluate the effectiveness of the MiLES intervention on several outcome measures on the level of the employee with cancer (time to RTW, quality of life, quality of working life, received work-related support, and satisfaction with work-related support), and the level of the employer (self-efficacy in providing RTW support, and satisfaction with the RTW process). Participants will be 140 employer-employee with cancer dyads. All dyads will randomly be allocated to the intervention group, of which the employer will get unlimited access to the MiLES intervention, or to the control group in which CAU will be provided. The follow-up of this study will be 12 months. Along with the RCT, a process evaluation using the UK Medical Research Council framework will also be conducted.
CONDITIONS
Official Title
Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with cancer less than 2 years ago
- Between 18 and 65 years old
- Currently in paid employment with an employer
- Receiving support from an occupational physician or reintegration consultant
- Currently fully or partly sick-listed for less than 2 years
- Able to understand and read Dutch to complete questionnaires
- Have informed or plan to inform their employer about their cancer diagnosis
- Not applied or planning to apply for an invalidity benefit under the WIA
- Employer supports the employee during sick leave and return to work (e.g., supervisor or HR manager)
- Employer able to understand and read Dutch to use the MiLES intervention and complete questionnaires
- Employer not previously familiar with the MiLES intervention
You will not qualify if you...
- Employees and employers must participate together as a dyad; if one cannot or will not participate, the other cannot participate either
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Arbo Unie
Arnhem, Netherlands
Actively Recruiting
2
Arbo Unie
Dordrecht, Netherlands
Actively Recruiting
3
Arbo Unie
Hengelo, Netherlands
Actively Recruiting
4
Re-turn
Utrecht, Netherlands
Actively Recruiting
5
Arbo Unie
Zeeland, Netherlands
Actively Recruiting
Research Team
J
Judith Mollet, MSc
CONTACT
M
Michiel Greidanus, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here